GR3032041T3 - Idebenone compositions for treating Alzheimer's disease. - Google Patents
Idebenone compositions for treating Alzheimer's disease.Info
- Publication number
- GR3032041T3 GR3032041T3 GR990403128T GR990403128T GR3032041T3 GR 3032041 T3 GR3032041 T3 GR 3032041T3 GR 990403128 T GR990403128 T GR 990403128T GR 990403128 T GR990403128 T GR 990403128T GR 3032041 T3 GR3032041 T3 GR 3032041T3
- Authority
- GR
- Greece
- Prior art keywords
- disease
- idebenone
- compositions
- treating alzheimer
- alzheimer
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title abstract 4
- JGPMMRGNQUBGND-UHFFFAOYSA-N idebenone Chemical compound COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O JGPMMRGNQUBGND-UHFFFAOYSA-N 0.000 title abstract 3
- 229960004135 idebenone Drugs 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14815493 | 1993-06-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3032041T3 true GR3032041T3 (en) | 2000-03-31 |
Family
ID=15446472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR990403128T GR3032041T3 (en) | 1993-06-18 | 1999-12-02 | Idebenone compositions for treating Alzheimer's disease. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0629400B1 (el) |
| JP (1) | JPH0761923A (el) |
| AT (1) | ATE184788T1 (el) |
| CA (1) | CA2125822A1 (el) |
| DE (1) | DE69420776T2 (el) |
| DK (1) | DK0629400T3 (el) |
| ES (1) | ES2136167T3 (el) |
| GR (1) | GR3032041T3 (el) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19549262C2 (de) * | 1995-02-08 | 1997-10-09 | Martin Dr Kohlmeier | Präparat zur Abschätzung des Entstehungsrisikos eines beschleunigten Verlustes kognitiver Fähigkeiten |
| EP0788793A1 (en) * | 1996-02-01 | 1997-08-13 | Takeda Chemical Industries, Ltd. | Idebenone for the treatment of dementia |
| AU3458997A (en) * | 1996-07-11 | 1998-02-09 | Takeda Chemical Industries Ltd. | Anti-beta-amyloid protein-induced cytotoxicity composition |
| US5962535A (en) * | 1997-01-17 | 1999-10-05 | Takeda Chemical Industries, Ltd. | Composition for alzheimer's disease |
| EP0952826B1 (en) * | 1997-01-17 | 2001-11-14 | Takeda Chemical Industries, Ltd. | Idebenone containing combination agent for treating alzheimer's disease |
| WO1999007355A1 (en) * | 1997-08-12 | 1999-02-18 | Takeda Chemical Industries, Ltd. | Idebenone-containing preparation for percutaneous administration |
| JP2003226639A (ja) * | 2002-01-31 | 2003-08-12 | Hisamitsu Pharmaceut Co Inc | 神経成長因子活性増強剤としてのビタミンｋ類を含む医薬組成物およびその使用 |
| AR055453A1 (es) * | 2004-01-06 | 2007-08-22 | Creactivar S A | Uso de la idebenona en una composicion destinada a ser aplicada sobre la piel y composicion que la comprende |
| EP2564843B1 (en) | 2005-06-01 | 2018-12-26 | Bioelectron Technology Corporation | Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| EP1986636B1 (en) | 2006-02-22 | 2013-04-24 | Edison Pharmaceuticals, Inc. | Phenol and 1,4-benzoquinone derivatives for use in the treatment of mitochondrial diseases |
| MX363223B (es) | 2008-09-10 | 2019-03-15 | Bioelectron Tech Corp | Tratamiento de trastornos generalizados del desarrollo con terapeuticos con actividad redox. |
| WO2014035356A1 (en) * | 2012-08-31 | 2014-03-06 | Mahmut Bilgic | Tablet formulations comprising a quinone derivative active agent |
| WO2017106803A1 (en) | 2015-12-17 | 2017-06-22 | Bioelectron Technology Corporation | Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders |
| US12274703B2 (en) | 2017-12-21 | 2025-04-15 | Gliapharm Sa | Compositions and methods of treatment for neurological disorders comprising a dementia |
| US12310967B2 (en) | 2017-12-21 | 2025-05-27 | Gliapharm Sa | Compositions and methods of treatment for neurological disorders comprising motor neuron diseases |
| WO2020132378A2 (en) | 2018-12-22 | 2020-06-25 | Gliapharm Sa | Compositions and methods of treatment for neurological disorders comprising depression |
| US20240269091A1 (en) | 2021-06-07 | 2024-08-15 | Katholieke Universiteit Leuven | Idebenone in the treatment of drug resistant epilepsy |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08768B2 (ja) * | 1989-08-24 | 1996-01-10 | 武田薬品工業株式会社 | 神経成長因子分泌誘導剤 |
-
1994
- 1994-05-27 EP EP94303847A patent/EP0629400B1/en not_active Expired - Lifetime
- 1994-05-27 ES ES94303847T patent/ES2136167T3/es not_active Expired - Lifetime
- 1994-05-27 DK DK94303847T patent/DK0629400T3/da active
- 1994-05-27 AT AT94303847T patent/ATE184788T1/de not_active IP Right Cessation
- 1994-05-27 DE DE69420776T patent/DE69420776T2/de not_active Expired - Fee Related
- 1994-06-08 JP JP6125606A patent/JPH0761923A/ja active Pending
- 1994-06-14 CA CA002125822A patent/CA2125822A1/en not_active Abandoned
-
1999
- 1999-12-02 GR GR990403128T patent/GR3032041T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69420776D1 (de) | 1999-10-28 |
| JPH0761923A (ja) | 1995-03-07 |
| EP0629400B1 (en) | 1999-09-22 |
| ATE184788T1 (de) | 1999-10-15 |
| EP0629400A1 (en) | 1994-12-21 |
| CA2125822A1 (en) | 1994-12-19 |
| DK0629400T3 (da) | 2000-02-14 |
| DE69420776T2 (de) | 2000-05-18 |
| ES2136167T3 (es) | 1999-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3032041T3 (en) | Idebenone compositions for treating Alzheimer's disease. | |
| EP0552256A4 (el) | ||
| CA2116559A1 (en) | Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases | |
| ZA956029B (en) | Combination treatment for inhibiting bone loss | |
| ZA874549B (en) | Compositions containing usnic acid or its derivatives for the therapeutical control of dental caries,particularly for the treatment of the cariogenic dental plaque | |
| IL86423A0 (en) | Pharmaceutical compositions for the treatment of alzheimer's disease | |
| GB2285219B (en) | Use of norastemizole for the treatment of allergic disorders | |
| GR3017855T3 (en) | Use of lithium in the treatment or prophylaxis of Molluscum contagiosum. | |
| ZA977644B (en) | Preventive or therapeutic drug for alzheimer's disease | |
| IL105475A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS | |
| GB2162748B (en) | Medicinal composition for the treatment or prevention of acne by oral administration | |
| GR3025372T3 (en) | Use of l-carnitine and acyl l-carnitines for treating patients suffering from aids-related syndromes and asymptomatic hiv-seropositive patients | |
| IL118833A (en) | Sertraline for use as a medicament in the treatment of post-myocardial infarction patients | |
| WO2001068076A8 (en) | D-enantiomer of dfmo and methods of use thereof for treating cancer | |
| GB9216297D0 (en) | Therapeutic agents | |
| SG54157A1 (en) | Use of ketorolac for treatment of periodontal disease | |
| EP0642338A1 (en) | USE OF (E) - 2 - (P -FLUOROPHENETHYL) - 3 - FLUOROALLYLAMINE FOR TREATING ALZHEIMER'S DISEASE. | |
| IL103499A0 (en) | Pharmaceutical compositions for treating anxiety in benzodiazepine withdrawn patients | |
| IL108191A0 (en) | Therapeutic compositions containing vitamin A | |
| IT1244714B (it) | Uso della benzidamina per il trattamento della placca dentaria |